Department of Obstetrics and Gynecology, Vanderbilt University School of Medicine, Women's Reproductive Health Research Center, Nashville, Tennessee, USA.
Fertil Steril. 2011 Mar 15;95(4):1295-301.e1. doi: 10.1016/j.fertnstert.2010.09.017. Epub 2010 Oct 8.
To examine the impact of a recent surgery on development of endometriosis-related adhesions in a chimeric model and to determine the therapeutic efficacy of pioglitazone (PIO).
Human endometrial biopsies were maintained in E(2) with or without PIO for 24 h before intraperitoneal injection into immunocompromised mice also treated with or without PIO at multiple time points after peritoneal surgery. The presence and extent of adhesions were examined in animals relative to the initial establishment of experimental endometriosis.
Medical school research center.
PATIENT(S): Endometrial biopsies for experimental studies were provided by normally cycling women without a medical history indicative of endometriosis or adhesions.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Examination of the development of endometriosis-related adhesions in an experimental model.
RESULT(S): Without therapeutic intervention, injection of E(2)-treated human endometrial tissue into mice near the time of peritoneal surgery resulted in multiple adhesions and extensive endometriotic-like disease. In contrast, PIO treatment reduced adhesive disease and experimental endometriosis related to surgical injury.
CONCLUSION(S): The presence of human endometrial tissue fragments in the peritoneal cavity of mice with a recent surgical injury promoted development of both adhesive disease and experimental endometriosis. Targeting inflammation and angiogenesis with PIO therapy limited the development of postsurgical adhesions associated with ectopic endometrial growth.
在嵌合模型中研究最近一次手术对子宫内膜异位症相关粘连发展的影响,并确定吡格列酮(PIO)的治疗效果。
将人子宫内膜活检标本在 E(2)中维持 24 小时,然后在进行腹膜手术后的多个时间点,向免疫功能低下的小鼠腹腔内注射 E(2)或 PIO。根据实验性子宫内膜异位症的初始建立情况,检查动物体内粘连的存在和程度。
医学院研究中心。
用于实验研究的子宫内膜活检标本来自没有子宫内膜异位症或粘连病史的正常循环女性。
无。
在实验模型中检查子宫内膜异位症相关粘连的发展。
在没有治疗干预的情况下,将 E(2)处理的人子宫内膜组织注射到接近腹膜手术时间的小鼠体内,导致多种粘连和广泛的子宫内膜样疾病。相比之下,PIO 治疗减少了与手术损伤相关的粘连性疾病和实验性子宫内膜异位症。
在最近接受手术损伤的小鼠腹膜腔内存在人子宫内膜组织碎片,促进了粘连性疾病和实验性子宫内膜异位症的发展。用 PIO 治疗靶向炎症和血管生成,限制了与异位子宫内膜生长相关的术后粘连的发展。